Wealth Enhancement Advisory Services
ABMD

Wealth Enhancement Advisory Services’s Abiomed Inc ABMD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,786
Closed -$1.32M – 343
2021
Q3 		$1.32M Buy
+3,786
New +$1.28M 0.02% 181
2020
Q2 		– Sell
-8,500
Closed -$1.4M – 265
2020
Q1 		$1.4M Buy
+8,500
New +$1.41M 0.05% 136
2019
Q2 		– Sell
-3,140
Closed -$823K – 247
2019
Q1 		$823K Sell
3,140
-163
-5% -$54.2K 0.05% 151
2018
Q4 		$1.1M Buy
3,303
+342
+12% +$119K 0.07% 108
2018
Q3 		$1.04M Sell
2,961
-150
-5% -$59.1K 0.06% 111
2018
Q2 		$1.28M Buy
+3,111
New +$1.13M 0.08% 93
2017
Q1 		– Sell
-6,052
Closed -$682K – 184
2016
Q4 		$682K Buy
+6,052
New +$701K 0.08% 126

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wealth Enhancement Advisory Services's ABMD Position: Q4 2021 in Review

Wealth Enhancement Advisory Services sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 3,786 shares — an estimated $1.32M sold.

Wealth Enhancement Advisory Services first reported a position in ABMD in Q4 2016 and held it in 7 quarters. The position peaked at $1.4M in Q1 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Wealth Enhancement Advisory Services reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 3,786 Abiomed Inc shares in Q4 2021, an estimated $1.32M.
  • Wealth Enhancement Advisory Services first reported a position in Abiomed Inc in Q4 2016 and held it in 7 quarters.
  • Wealth Enhancement Advisory Services's Abiomed Inc position peaked at $1.4M in Q1 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2021, filed 8 Feb 2022.